Zydus Lifesciences Enters Settlement Agreement With Astellas Over Myrbetriq
ReutersFeb 12, 2026 3:02 AM
Feb 12 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS:
ZYDUS LIFESCIENCES - ENTERS SETTLEMENT AGREEMENT WITH ASTELLAS OVER MYRBETRIQ
ZYDUS LIFESCIENCES - TO PAY ASTELLAS USD 120 MILLION
ZYDUS LIFESCIENCES - TO PAY LICENSING FEE ON GENERIC MIRABEGRON
ZYDUS LIFESCIENCES - SETTLEMENT CONCLUDES LITIGATIONS, ZYDUS TO MARKET GENERIC MIRABEGRON
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
Strategy Defies DAT Sell-Off, Doubles Down Amid Leverage Woes
MicroStrategy acquired over 1,000 additional Bitcoins last week, with Michael Saylor stating the company will purchase Bitcoin every quarter moving forward.TradingKey
21 hours ago
Silver Faces Sixth Consecutive Year of Supply Deficit, How Much Upside Is Left in 2026?
TradingKey - According to the 2026 Silver Market Outlook recently released by the Silver Institute, the current robust performance of the silver market remains supported by solid fundamentals. The report indicates that the global silver market is expected to face a structural supply-demand imbalanceTradingKey
Wed, Feb 11
Retail Trading Hub Robinhood Sinks Again, Slumping Over 7% After Hours, Signaling Lack of Interest in Crypto?
TradingKey - Robinhood (HOOD) reported a 34% decline in fourth-quarter net profit to $605 million, with total revenue of $1.28 billion missing Wall Street expectations.TradingKey
Wed, Feb 11
Solana Price Prediction: How Much Is SOL Now? Can It Rise to $1,000 in the Future?
SOL prices started below $1 in 2020, surged to $260 in 2021, and neared $300 in 2025 to reach a new all-time high, primarily driven by the explosion of the Solana ecosystem and the Bitcoin halving cycle. Although the market may face cyclical downside risks in 2026, institutions remain generally bullTradingKey
Fri, Jan 23
